# v4.0

## Related releases

## Data changes
Alteration:
ACTG1 Truncating Mutations, Mutation Effect Description Updated
ACVR1 Q207E, Mutation Effect Description Updated
AGO2 R812A, Oncogenicity Updated
	 New: Likely
	 Old: Inconclusive
AGO2 R583A, Oncogenicity Updated
AGO2 Q545A, Oncogenicity Updated
AGO2 R647A, Oncogenicity Updated
AJUBA Truncating Mutations, Mutation Effect Description Updated
AKT2 Fusions, Mutation Effect Description Updated
ALK G1128S, Oncogenicity Updated
	 New: Inconclusive
	 Old: Likely Neutral
ANKRD11 Truncating Mutations, Mutation Effect Description Updated
ASXL1 Deletion, Mutation Effect Description Updated
ATP6AP1 L98S, Mutation Effect Description Updated
ATP6AP1 R71H, Mutation Effect Description Updated
ATP6V1B2 Truncating Mutations, Mutation Effect Description Updated
ATXN2 Truncating Mutations, Mutation Effect Description Updated
ATXN7 RAD51C-ATXN7 Fusion, Mutation Effect Description Updated
AXIN1 Deletion, Mutation Effect Description Updated
BRAF I592_A598dup Added
BRCA1 K1487R, Oncogenicity Updated
	 Old: Likely
BRCA1 H1283Y, Mutation Effect Description Updated
BRCA1 N473S, Mutation Effect Description Updated
BRCA2 V1839_E1901del, Oncogenicity Updated
	 New: Resistance
BRCA2 S1869_N1877del, Oncogenicity Updated
BRCA2 S1871_C1893del, Oncogenicity Updated
BRCA2 S1834_G1892del, Oncogenicity Updated
BRCA2 K1872*, Mutation Effect Updated
	 New: Likely Loss-of-function
BRCA2 R259fs*15, Mutation Effect Updated
BRCA2 V1790_A1996del, Oncogenicity Updated
BRCA2 A1847_M1890del, Oncogenicity Updated
BRCA2 T1815_Y1894del, Oncogenicity Updated
BRCA2 V2466A Name Changed
	 New: V2466A
	 Old: A2466V
BRCA2 V2466A, Mutation Effect Description Updated
CARM1 S217E, Mutation Effect Updated
	 Old: Likely Loss-of-function
CARM1 S217T, Mutation Effect Updated
CARM1 S217C, Mutation Effect Updated
CDKN2A D108H Added
CDKN2A Q50R Added
CDKN2A Q50H Added
CREBBP K1320R, Oncogenicity Updated
	 New: Likely Neutral
CSF1R Fusions, Mutation Effect Description Updated
CXCR4 R334*, Mutation Effect Description Updated
CXCR4 Amplification, Mutation Effect Description Updated
DUSP4 Truncating Mutations, Mutation Effect Description Updated
EGFR T854A, Oncogenicity Updated
ELF3 I279P, Oncogenicity Updated
FLCN Truncating Mutations, Mutation Effect Description Updated
GNAQ Q209P, Mutation Effect Description Updated
HNF1A I27L Added
HOXB13 G84E, Oncogenicity Updated
ID3 Truncating Mutations, Mutation Effect Description Updated
JAK2 R277K, Oncogenicity Updated
	 Old: Yes
JAK2 Y931C, Mutation Effect Updated
	 New: Likely Gain-of-function
JAK2 L983F, Oncogenicity Updated
JAK2 D544H, Oncogenicity Updated
JAK2 G417P, Oncogenicity Updated
JAK2 R683T, Mutation Effect Updated
JAK2 S1025C, Oncogenicity Updated
JAK2 I1018W, Oncogenicity Updated
JAK2 I1018F, Oncogenicity Updated
JAK2 W1038C, Oncogenicity Updated
JAK2 F1061W, Oncogenicity Updated
JAK2 Y1045*, Oncogenicity Updated
JAK2 Y1045W, Oncogenicity Updated
JAK2 L1026F, Oncogenicity Updated
JAK2 V1075F, Oncogenicity Updated
JAK2 S1039F, Oncogenicity Updated
KBTBD4 R313delinsPRR, Oncogenicity Updated
KBTBD4 P311delinsPP, Oncogenicity Updated
MAP2K1 I111N, Oncogenicity Updated
MAP2K1 V154I, Oncogenicity Updated
MAP2K1 H119P, Oncogenicity Updated
MAP2K1 L115R, Oncogenicity Updated
MET T992I, Mutation Effect Updated
	 Old: Likely Gain-of-function
MITF Truncating Mutations, Mutation Effect Description Updated
NOTCH3 1972_2321trunc [C-terminal truncating mutations], Mutation Effect Updated
NOTCH3 1_1972trunc [N-terminal truncating mutations], Mutation Effect Updated
NUP93 Exon 13 deletion, Oncogenicity Updated
NUP93 K442Nfs*, Oncogenicity Updated
NUP93 G591V, Oncogenicity Updated
NUP93 Y629C, Oncogenicity Updated
PDGFRB L658P (germline), Oncogenicity Updated
PDGFRB R987W (germline), Mutation Effect Description Updated
PIK3CA E78K, Oncogenicity Updated
PTPRS Truncating Mutations, Mutation Effect Description Updated
ROS1 L1951R, Oncogenicity Updated
SHOC2 M173I, Oncogenicity Updated
SMAD4 D537A Added
SMAD4 D537V Added
SMAD4 D537G Added
SMO E518A, Oncogenicity Updated
SMO D473Y, Oncogenicity Updated
TERT H412Y, Oncogenicity Updated
TERT P704S, Oncogenicity Updated
TERT Y846C, Oncogenicity Updated
TERT H876Q, Oncogenicity Updated
TERT Promoter [Promoter Mutation], Oncogenicity Updated
TERT R1084*, Oncogenicity Updated
TERT L392Vfs*146, Oncogenicity Updated
TERT P308Hfs*43, Oncogenicity Updated
TFE3 PRCC-TFE3 Fusion Added
TP53 C277Y Added
TP53 Y236H Added
TP53 Y236N Added
TP53 H193Q Added
TP53 H193D Added
TP53 H193Y Added
TP53 H193L Added
TP53 Y163D Added
TP53 Y163H Added
TP53 V274A Added
TP53 V274D Added
TP53 C277F Added
TP53 V274G Added
TP53 V274L Added
TP53 G244A Added
TP53 G244C Added
TP53 G244V Added
TP53 G244F Added
TP53 C135Y, Mutation Effect Description Updated
VHL Y112C Added
VHL W117L Added

Evidence:
FGFR1 Amplification, Lung Squamous Cell Carcinoma, Tumor Type Summary Updated
FGFR1 Amplification, Other Tumor Types, Tumor Type Summary Updated
FGFR1 Amplification, Lung Squamous Cell Carcinoma, Debio1347, Infigratinib, Erdafitinib  Updated
FLT3 572_630ins [Internal tandem duplication], Acute Myeloid Leukemia, Crenolanib  Updated
KRAS G12C, Non-Small Cell Lung Cancer, Tumor Type Summary Updated
KRAS G12C, Non-Small Cell Lung Cancer, Adagrasib 1 Added
KRAS G12C, Other Solid Tumor Types, Tumor Type Summary Updated
KRAS G12C, Non-Small Cell Lung Cancer, Adagrasib 3A Deleted

